Related by context. All words. (Click for frequent words.) 73 PAION AG 73 Therapeutic Competitors companiesandmarkets.com adEgemonye 72 News Unternehmensnachrichten DGAP Adhoc 72 Announcement acc 71 Inc Therapeutic Competitors 71 WILEX AG 71 DJ DGAP IRE 70 Ltd Therapeutic Competitors 70 MorphoSys AG FSE MOR 69 Miscellaneous #.#.# Release 69 elexis AG 69 Submits Response 69 Receives Milestone Payment 69 Completes Patient Enrollment 68 Therapeutic Competitors Report 68 DGAP Ad hoc 68 Therapeutic Competitors Companies 68 Taglich Brothers Initiates Coverage 68 Therapeutic Competitors 68 Sanochemia Pharmazeutika AG 68 Tibotec BVBA 68 Initiates Enrollment 68 ots.CorporateNews transmitted 68 Receives NASDAQ 68 News Unternehmensnachrichten DGAP 68 Initiates Clinical 68 Retains CCG Investor Relations 68 Flamel Technologies Announces 67 Jumps Higher 67 Quarterly Report Announcement 67 Files Shelf Registration Statement 67 Gerd Zettlmeissl CEO 67 BioSante Pharmaceuticals Announces 67 Initiates Phase II 67 OPENLiMiT Holding AG 67 DJ EANS Adhoc 67 Mergers Acquisitions Takeovers 67 MOLOGEN AG 67 News Aktienkurs Preliminary 67 Provides Clarification 67 Presents Positive Preclinical 67 NASDAQ CRXL 67 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 67 Explores Strategic Alternatives 67 Submits IND 67 FY# Loss Widens 67 Amex KAL 66 Q1 Adj 66 Review Strategic Alternatives 66 PharmaVitae Profile 66 Receives Marketing Authorization 66 Initiates Clinical Trial 66 Alstria Office AG 66 Partnering Agreements 66 Announces Poster Presentations 66 DGAP PVR 66 Receives Orphan Drug Designation 66 Orexo AB 66 INTERNATIONAL HOLDINGS INC. 66 EQS Adhoc 66 Board Unanimously Rejects 66 Files Investigational 66 euro adhoc Stimmrechte 66 BioGlue ® 66 Receives CE Marking 66 Japanese Encephalitis Vaccine 66 Submits NDA 66 Receive Milestone Payment 66 Successfully Concludes 66 Evotec AG 66 Announce Collaboration Agreement 66 IPSEN 66 Reveals Receipt 66 Crucell NV NYSE Euronext 66 Q4 Profit Decreases 66 AG deutsch 66 SoftM AG 66 Paris IPN Euronext 66 Presents Positive 66 Joins OTCQX 66 Gedeon Richter Plc 66 FY# Loss Narrows 66 Begins Dosing 65 Receives Approvable Letter 65 TapImmune Inc. 65 TRACON Pharmaceuticals 65 Intercell AG 65 ASE SVA 65 Receives Clearance 65 Nasdaq CRXL 65 Gendux AB 65 Successfully Completes Phase 65 Files Shelf Registration 65 MBRX 65 Initiates Clinical Trials 65 Markettelegraph.com 65 Submits Application 65 AMEX RGN 65 Nasdaq CYTX 65 Enters Into Collaboration 65 Initiates Phase III 65 Triplan AG 65 Fresenius Biotech 65 Initiates Dosing 65 AB OMXS BINV 65 -Luiza 65 Begins Shipment 65 EANS Stimmrechte 65 Solteq Oyj 65 Immunotherapeutic 65 Enzon Pharmaceuticals Inc 65 Obtains License 65 Announces Reverse Split 65 ThromboGenics NV 65 Kiadis 65 Provides Update Regarding 65 Inovio Pharmaceuticals 65 APA ots news 65 Regains NASDAQ 65 International Brachytherapy sa 65 PROCON MultiMedia AG 65 Receives Orphan Drug 65 KEYP 65 IG HCR ;) CO 65 SWOT Analysis Aarkstore Enterprise 65 Files IND 65 Amend Merger Agreement 65 VERBIO Vereinigte BioEnergie AG 65 Widens Quick Facts 65 AIXTRON AG FSE AIX 65 EANS News 65 NASDAQ CYTX 65 Receives Fast Track 65 Receives Favorable 65 OTCBB NNVC 65 Receives Complete Response 65 Director Shareholding 65 Receives Unsolicited 64 Amends Agreement 64 Nasdaq EPCT 64 Extends Collaboration 64 Idenix Pharma 64 Sinks Lower 64 TSX Delisting Review 64 visit www.targanta.com 64 Arno Therapeutics 64 Nasdaq AVNC 64 Announces Divestiture 64 PAION AG ISIN 64 BTG plc 64 Completes Restructuring 64 bioMerieux SA 64 GTC NASDAQ GTCB 64 SBL Vaccines 64 NASDAQ GTCB 64 GTC recombinant form 64 Presents Preclinical 64 Wilex AG 64 Strengthens Balance Sheet 64 Semiannual Financial 64 Submits Biologics License Application 64 ENSL 64 Milestone Payments 64 Announce License Agreement 64 Süss MicroTec AG 64 Beteiligungsges 64 Penwest Pharmaceuticals Co 64 Inc. www.micromet inc.com 64 WEBBOLT Petrochemicals 64 Alnylam Nasdaq ALNY 64 COLEXON Energy AG 64 Rhein Biotech NV 64 Files Patent Application 64 Completes Dosing 64 Actelion Pharmaceuticals Ltd 64 BioGlue R 64 Stock Exchange EVT 64 Gets FDA Clearance 64 Granted Orphan Drug 64 Terminates Merger Agreement 64 Alnylam Pharma 64 Cyclacel Pharmaceuticals 64 Restructures Operations 64 Demonstrates Significant 64 Unsolicited Proposal From 64 Idera Pharmaceuticals 64 Stockwire.com OTC 64 AMEX BVX 64 Ulrich Dauer CEO 64 Handok Pharmaceuticals 64 OTCBB PYTO 64 Q1 Loss Narrows 64 Sunesis Pharma 64 Nasdaq OSIP 64 Evotec AG Frankfurt 64 Tech DVAX 64 technology visit http:/www.genmab.com 64 Announces Postponement 64 FDA Accepts 64 übermittelt durch euro adhoc 64 Begin Clinical Trials 64 Sinobiomed Inc. 64 Provides Shareholder 64 Stimmrechte 63 ASX PGL 63 Shareholders Approve Acquisition 63 Seasonal Influenza Vaccine 63 Plaut Aktiengesellschaft 63 DATA MODUL AG 63 BioGeneriX 63 Nasdaq CYCC Nasdaq CYCCP 63 TNGN 63 IXIARO ® 63 Astex Therapeutics 63 Exploring Strategic Alternatives 63 Reports Preclinical Data 63 SWOT Analysis www.companiesandmarkets.com adds 63 NOVN 63 OTCBB CAEH 63 Newron Pharmaceuticals SpA 63 Announces Effective Date 63 Receives Notification 63 Veröffentlichung einer Mitteilung nach 63 Tyrian Diagnostics 63 Enrolls First 63 N.V. 63 Antisoma plc 63 Submits Supplemental 63 NGSX 63 Bellus Health 63 Company Report companiesandmarkets.com 63 Potelligent Technology 63 Nasdaq IDIX 63 Announce Licensing Agreement 63 t2cure GmbH 63 PRAECIS PHARMACEUTICALS INCORPORATED 63 Psivida 63 Amvescap PLC UK 63 Engages CHF Investor Relations 63 Projected Release Date 63 Veröffentlichung gemäß § 63 Q3 Adj 63 DGAP DD 63 R MSCRAMM 63 NV Euronext 63 Regeneron Pharma 63 NYSE NVO 63 Xoma Ltd 63 Initiates Phase 2b 63 Receives Favorable Ruling 63 Nasdaq VRTX today 63 Endures Analyst Downgrade 63 Germany FSE SCH 63 Neose Technologies 63 NASDAQ VRTX 63 CONBRIZA 63 Nanophase Announces 63 DGAP Stimmrechte 63 Regulatory Announcement 63 Newron Pharmaceuticals 63 Nasdaq APPY 63 P#X# antagonist 63 Q4 Profit Climbs 63 BayStreet.ca Research Alert 63 Q2 Adj 63 Partnering Guide 63 Osmetech plc 63 Semperit AG Holding 63 Civacir 63 Mymetics Corporation 63 Q1 Profit Decreases 63 Pluristem Therapeutics 63 Innogenetics NV 63 Licenses Novel 63 Inc SPPI 63 Antisense Pharma GmbH 63 Deutsche EuroShop AG 63 Jerini AG 63 please visit www.advaxis.com 63 Syntonix Pharmaceuticals 63 Successfully Completes Tender Offer 63 Presents Preclinical Data 63 ENZON 63 Q3 Loss Narrows 63 HuMax HepC TM 63 DJ EANS PVR 63 Combination REOLYSIN R 63 Iomai Corporation 63 ItN Nanovation AG 63 Pharmexa Epimmune 63 NorDiag 63 EANS Tip Announcement 63 visit www.genmab.com 63 Inc. NASDAQ ORXE 63 CENIT AG Systemhaus 63 VivaGel ™ 63 CeNeS Pharmaceuticals plc 63 ViRexx Announces 63 OMRIX Biopharmaceuticals 63 Diatos SA 63 Terminates Agreement 63 Obtains Exclusive License 63 NASDAQ FLML 62 PETROTEC AG 62 KEMIRA 62 OTCBB IMNR 62 Uvidem 62 Obtains Approval 62 Restructures Debt 62 Nasdaq NPSP 62 Nasdaq DVAX 62 HuMax TAC 62 STRABAG SE 62 OTCBB HXBM developer 62 Taiho Pharmaceutical 62 Completes Reorganization 62 ISIN AT# 62 DOR BioPharma Announces 62 Completes Restatement 62 Biotest AG 62 Announces Tentative Approval 62 Inks MOU 62 Completes Previously Announced 62 Pharmos Corporation 62 Strengthens Position 62 Astex Therapeutics Limited 62 Medoro Resources Announces 62 successfully commercialize Iluvien 62 Inc. LATEST NEWS 62 TKPHF 62 GenSci 62 Commences Phase 62 AllPennyStocks.com Spotlights 62 Nasdaq IDRA today 62 WCH GY 62 Confirms Efficacy 62 Puts Sold 62 TSX CTI 62 GILD GILD 62 Expands Scientific Advisory 62 Q3 Loss Widens 62 AG Veröffentlichung einer Mitteilung 62 Biovitrum AB 62 Viatris 62 Reacquires 62 Secures Financing 62 TSX SHQ 62 Trubion Pharma 62 Heliad Equity Partners 62 + Medien AG 62 -Muzzys 62 Nasdaq KOSN 62 Silence Therapeutics plc 62 Drägerwerk AG & 62 Inc. Amex VRA 62 Subsidiary Enters 62 Commences Phase III 62 Biotie Therapies 62 Deutsche Effecten und Wechsel 62 visit http:/www.martek.com 62 Receives Tentative Approval 62 Q2 Loss Narrows 62 AMEX DDD 62 Addex Pharmaceuticals 62 Virosome Biologicals 62 Issues Clarification 62 Genelabs Technologies 62 OTCBB CHKT 62 Nasdaq SCLN 62 Announce Early Termination 62 NDA Submission 62 Earns Milestone Payment 62 Nasdaq PARD 62 Reports Receipt 62 #.#.# Dissemination 62 Alligator Bioscience AB 62 Reports Significantly Improved 62 Attracting Bullish Investors 62 Biofrontera AG 62 SOLON AG für Solartechnik 62 Announces FDA Clearance 62 proprietary capillary aerosolization 62 Aloxi ® 62 DJ HUGIN NEWS 62 First Patient Treated 62 Receives Shareholder Approval 62 Milestone Payment 62 NASDAQ SHPGY 62 SynCon 62 ACADIA Pharmaceuticals 62 DELTON AG 62 commercializing Loramyc ® 62 Vitaflo Scandinavia AB 62 LSE SHP.L 62 Nasdaq GORX 62 PLC Director PDMR 62 JV SpeBio 62 AMEX IVX LSE IVX.L 62 QRxPharma Limited 62 ESBATech AG 62 Pieris AG 62 Regains Nasdaq 62 Commence Phase 62 OTCBB HNAB 62 Immunomedics Announces 62 CysDisplay R 62 Announce Merger Agreement 62 Xcite Energy Limited 62 Nasdaq XTLB 62 Signs Non Binding 62 Nasdaq TARG 62 Welcomes Analyst Initiation 62 SOBI 62 DayTradersDigest.com Profiles 62 SHARE HOLDER 62 Crucell NV Euronext 62 PSDV 62 Announces Dosing 62 Ohr Pharmaceutical Inc. 62 Announce Commencement 62 markets HP Acthar 62 SWX RO SWX ROG 62 OTCBB ILNS 62 Bacterin develops manufactures 62 3U HOLDING AG 62 Patient Enrollment 62 co licensor KDL 62 INDICATED LOWER 62 Rhein Biotech GmbH 62 Receives Positive 62 ONCY 62 Systemic Delivery 62 Quarter Results #.#.# 61 Logwin AG 61 NOTE TO SUBSCRIBERS 61 BioMarin Pharma 61 Inc. Nasdaq MITI 61 Enters Into Licensing Agreement 61 ARBOmedia AG 61 & Recapitalisations 61 Pepscan Therapeutics 61 PROLOR Biotech Inc. 61 Q4 Loss Widens 61 Bullish Technical Alert 61 Nasdaq BJGP 61 Mühlbauer Holding AG 61 Receives Notice From 61 Holdings HKSE # 61 Therapeutic Vaccine 61 AMEX ONI 61 NASDAQ BJGP 61 Receives Conditional 61 BioPhausia 61 Receives Anticipated 61 AGRANA Beteiligungs AG 61 Allbecon Olympia AG 61 Active Biotech AB 61 Exercises Warrants 61 Myrexis Inc. 61 Healthnostics Announces 61 Closes Merger 61 TELES AG 61 ALPMF 61 Vernalis plc 61 Auxilium Pharma 61 OTC BB PVCT 61 Nasdaq ZIOP 61 Marinomed 61 Ticker Symbol Change 61 biotherapeutic drugs 61 Settle Patent Litigation 61 Stock Exchange EVT TecDAX 61 MEDIA LIMITED 61 subsidiaries visit http:/www.apricusbio.com 61 NASDAQ Listing Requirements 61 SPL# Gel vaginal microbicide 61 AMEX PTN 61 DJ DGAP PVR 61 Revises Third Quarter 61 JENOPTIK AG 61 PPD Declares 61 Mingyuan Medicare Development 61 Completes Buyout 61 Biotie Therapies Corp. 61 Sidec 61 VERBIO 61 NASDAQ STAA 61 Releases Audited 61 BTRX 61 Completes Patient Enrolment 61 Inc. NASDAQ EVVV 61 Nasdaq Delisting Notice 61 MISYS PLC 61 Unicredit reste à acheter 61 Nasdaq ANDS 61 narrows Quick Facts 61 Pironet NDH AG 61 Announces Stockholder Approval 61 Intravenous Human 61 Nasdaq MNKD 61 Completes Enrollment 61 OTCBB NPHC 61 Meets Primary Endpoint 61 Tyzeka Sebivo 61 Signs Definitive Merger Agreement 61 Pressemappe -Board WELB 61 Pevion Biotech 61 Beats Raises Guidance 61 Terminate Merger Agreement 61 Inc. Nasdaq NSTK 61 Loss Narrows Quick Facts 61 Evaluate Strategic Alternatives 61 Acquires Remaining Interest 61 NASDAQ SAMAS 61 Files Annual Report 61 Protherics PLC announces 61 NASDAQ ENMD 61 TriCo Bancshares Announces 61 NOXXON Pharma AG 61 AGM EGM #.#.# 61 TAG Tegernsee Immobilien und 61 acetonide FA 61 License Option Agreement 61 Web Site http:/www.cryolife.com 61 TSX NVN 61 KRYSTEXXA TM pegloticase 61 antibacterial therapeutics 61 Reiterates Fiscal 61 VCRT 61 BFRM 61 Approves Stock Repurchase 61 Announces Spin Off 61 Teva Provides Update 61 Positive Opinion 61 Identifies Potential 61 Syzygy AG 61 NASDAQ IDIX 61 Nasdaq AUXL 61 Thewallstreetleader.com Profiles 61 Stereotaxis Announces 61 XIAPEX 61 Clavis Pharma ASA 61 DJ DGAP DD 61 Declares Dividend Quick Facts 61 Signs Merger Agreement 61 Q2 Loss Widens 61 QIAGEN QGEN 61 Rotarix R 61 Nasdaq RXII 61 Canaccord Genuity Maintains Hold 61 SYCREST 61 Euronext Brussels GLPG 61 Antithrombin 61 BRGO 61 Net Profit Surges 61 Nabi HB R 61 Merz Pharma GmbH 61 FURX 61 Xcytrin R 61 Announces Licensing Agreement 61 Hold Third Quarter 61 Berna Biotech AG 61 Creabilis Therapeutics 61 http:/www.sunesis.com 61 Influenza Vaccine 61 Narrows Quick Facts 61 StaphVAX R 61 Nasdaq ACHN 61 SOLVAY PHARMACEUTICALS 61 SinuNase ™ 61 ASX BLT 61 WKN # ISIN DE# 61 mit dem Ziel einer 61 Adenuric R 61 IMW Immobilien AG 61 Omacor ® 61 Guides FY# Update 61 Completes Recapitalization 61 Announces Restatement 61 Company OTCBB CXDC 61 Breakthroughstocks.net EXPLOSIVE news 61 Achieves Primary Endpoint 61 Crofelemer budesonide foam 61 Inc. OTCBB SYBD 61 Dynepo TM 61 Caleco Pharma 61 Nasdaq PGNX 61 NASDAQ VPHM 61 #.#.# Meldung [003] 61 NOVAVAX 61 Reaffirms Outlook 61 elbion GmbH 61 Sign Licensing Agreement 61 Inc. NASDAQ IDMI 60 ChemGenex Pharmaceuticals Limited 60 Q4 Adj 60 DJ DGAP CMS 60 OTC BB NNVC.OB 60 otcstockexchange.com 60 Sets Record Date 60 Berlin Hannover München 60 CRMD# 60 personalized dendritic 60 Quick Facts2 60 Diamyd Medical Diamyd 60 Announces Effectiveness 60 Inc. Nasdaq OXGN 60 AT# [004] 60 Announces Debt Refinancing 60 Drug Candidate 60 Intercell AG VSE ICLL 60 Patent Issued 60 -leukemias 60 DGAP ein Unternehmen der 60 Taisho Pharmaceuticals 60 NASDAQ ARRY 60 STOCK EXCHANGE ANNOUNCEMENT #.#.# 60 Confirms Guidance 60 OTCBB GNTA 60 Regains Compliance With 60 Serica Energy plc Serica 60 NewsBite Downgrade Puts Pressure 60 Locteron exclusively 60 Nasdaq SMTS develops manufactures 60 NASDAQ ALNY 60 Announces Cancellation 60 SHP.L 60 Receives Stockholder Approval 60 Addex Pharmaceuticals Ltd. 60 Announces Initiation 60 Lupus Drug 60 Alternext ALEHT 60 HuCAL GOLD R 60 Receives Approval From 60 Closes Oversubscribed 60 China Aoxing Pharmaceutical 60 Finalizes Purchase 60 Merck Serono SA 60 Increlex TM 60 Nasdaq CYCC 60 NASDAQ AEZS 60 Protherics PLC 60 NASDAQ BDSI 60 Guides Inline 60 Completes Financing 60 Awarded Patents 60 Immunomedics Inc 60 widens Quick Facts 60 Long P.A. Announces 60 HUGIN NEWS 60 Nasdaq CADX 60 Nasdaq IDRA 60 Receives Delisting Notification 60 Explore Strategic Alternatives 60 hyperimmune products 60 Nasdaq IMGN 60 Recombinant Human 60 Successfully Closes 60 CYOE 60 Nasdaq ICOS 60 Reports Inducement Grants 60 Ltd. Joins OTCQX 60 Receives Authorization 60 Fast Track Status 60 MagForce Nanotechnologies AG 60 Crowflight Announces 60 Guidance Reaffirmed 60 Wolf Haldenstein Investigating 60 Please visit www.antisoma.com 60 NYSE Amex PTN 60 Reports Positive 60 Nasdaq CGEN 60 Diagnostica 60 Crucell NV NASDAQ CRXL 60 CRXL 60 include Altastaph TM 60 Inc. Nasdaq NEOL 60 Pending Acquisition 60 SWX SPPN 60 Agennix AG 60 UGNE 60 apricitabine ATC 60 Alvesco ® 60 Reach Settlement Agreement 60 SSRX 60 Submits Investigational 60 Complies With 60 Completes Acquisitions 60 Announces Adjournment 60 InVision Software AG 60 Initiates Quarterly Dividend 60 Nobilon 60 Napo Pharmaceuticals 60 DARA logo 60 Nasdaq Deficiency Notice 60 please visit http:/www.atherogenics.com 60 Canaccord Genuity Reiterates Buy 60 Elektrobit Corporation 60 Sign Definitive Merger 60 Key Milestones 60 B.V. 60 Transdermal Patch 60 Nasdaq INHX 60 Gout Drug 60 Shows Promising 60 Receives SFDA Approval 60 NV Organon 60 plc Director PDMR 60 bmp AG 60 PuriCore plc 60 Proposed Buyout 60 MBMI Closes 60 Eurand Pharmaceuticals 60 Cosmo Pharmaceuticals 60 CLAVIS 60 NASDAQ ONXX 60 please visit www.medicinova.com 60 NRGN 60 Aspreva Pharmaceuticals Corporation 60 GRAS Status 60 Inotek Pharmaceuticals Corporation 60 Covalon Technologies 60 NASDAQ TRBN 60 Hold Second Quarter 60 Opko Health Inc. 60 Tripep 60 Antibody Discovery 60 Hold Fourth Quarter 60 MEDAREX 60 Ups Guidance 60 Jiangbo Pharmaceuticals 60 CeoTronics AG 60 Receives Delisting Notice 60 Chugai Pharma 60 Axentis Pharma 60 Sanochemia 60 NASDAQ INGN 60 NASDAQ SLXP 60 developing Zerenex ferric 60 OTCBB IGXT 60 Optimer Pharma 60 Rated Speculative Buy 60 Valera Pharmaceuticals 60 Restate Financial 60 Nasdaq NABI 60 NASDAQ MOGN 60 4SC AG ISIN DE# 60 Alnylam ALNY 60 Increases Ownership 60 Announces Repurchase 60 NYSE AMEX IBIO 60 BIOTECHNOLOGY SOURCE 60 AGOR AG 60 Regains Full 60 Tripep AB 60 Figures Balance Sheet 60 Bearish MACD 60 Updates Guidance 60 EURX 60 Apricus Biosciences 60 FJH AG 60 Q4 Loss Narrows 60 TriPath Oncology 60 Q1 Loss Widens 60 MEDA AB publ 60 NASDAQ ADLR 60 COMUNICADO DE 60 Gets Bearish Confirmation 60 Inc. NASDAQ AGIX 60 Completes Reverse Merger 60 Receives Positive Opinion 60 visit www.genenews.com 60 Plethora Solutions Holdings 60 ISIN DE # 60 Sets Second Quarter 60 Calls Purchased 60 Milestone Payment From 60 Bullish Average Crossover 60 Actelion Ltd 60 NASDAQ BMRN 60 Successfully Completes Acquisition 60 Rheumatoid Arthritis Drug 60 Agendia BV 60 Q4 Profit Soars 60 evaluating bafetinib 60 Epiphany Biosciences 60 Initiate Clinical Trial 60 UMN Pharma 60 Board Authorizes 60 Achieves Significant 60 Closes Previously Announced 60 ABLYNX 60 targeted anticancer biopharmaceuticals 60 Nasdaq PHRM 60 Company www.clxinvestments.com holds 60 Clinical Trial Results 60 XOMA XOMA 60 Vancocin R 60 R DYNACIN R 60 Q3 Profit Climbs 60 CropEnergies AG 60 www.clenergen.com 60 Sampo Plc 60 REG1 Anticoagulation System 60 Adjuvanted 60 Vicor Technologies Announces 60 Nasdaq SLXP 60 prescription brands RESTYLANE 60 Commences Mailing 60 Sign License Agreement 60 AMAG Pharma 60 Akorn Inc 60 Gets Clearance 60 Moving Average Crossover Alert 60 Migraine Drug 60 OTCBB HPLF FWB HL1 60 NYSE Amex PBTH 60 Medivir AB 60 Thomson Reuters ONE 60 Tibotec Pharmaceuticals Ltd. 60 Boosts Qtr 60 Biodel Inc 60 Announces Issuance 59 Cavit Sciences Inc. 59 Vs Pft 59 MindUp BioResearch 59 Sanofi NYSE SNY 59 Demonstrates Sustained 59 Unsolicited Tender Offer 59 liver resection surgeries 59 epoetin zeta 59 Files Preliminary Prospectus 59 Nasdaq GTCB 59 NASDAQ PGNX 59 Wien euro adhoc 59 Daiichi Suntory Pharma 59 NASDAQ NABI 59 :/ finance.yahoo.com q 59 Corp. KNSY 59 Antitumor 59 Biopharmaceuticals AG 59 MONSTERSTOX.COM Monsterstox.com 59 Daytradersdigest.com 59 Bearish Speculation 59 TELEPERFORMANCE 59 Nanobody R 59 Panflu TM 59 RGIN 59 Proteo Biotech AG 59 StockPreacher.com Issues Trading 59 Files Definitive Proxy 59 Berlin München Düsseldorf 59 TSX BLU 59 Calcium Acetate 59 Presenter Profiles 59 Subsidiary Acquires 59 Vion Pharmaceuticals 59 Investigational Compound 59 NASDAQ ALTU 59 Registration Statement Declared Effective 59 TSX OBP 59 NASDAQ CGPI 59 FLDM 59 Bullish Speculation 59 Completes Tender Offer 59 WORLDWIDE INC. 59 Novel Antibiotic 59 Inc. Nasdaq TRMS 59 ProtAffin 59 Altana Pharma 59 LYON France BUSINESS WIRE 59 Basilea Pharmaceutica AG 59 Biopharm 59 Releases Third Quarter 59 Nasdaq ORCT 59 SCHWARZ PHARMA 59 Eurand NV EURX 59 Jerry Newmin 59 KAI Pharmaceuticals Inc. 59 PDL BioPharma Announces 59 Closes Second Tranche 59 Announce Shareholder Approval 59 Terminates Contract 59 Trubion Pharmaceuticals TRBN 59 -Eurocan 59 Resubmission 59 FY# Profit Surges 59 Settle Litigation 59 Zhejiang Hisun 59 Fero Industries Inc. 59 OTCStockExchange.com Stock Alert 59 Reveals Positive 59 Pivotal Phase III 59 Phase 2a Trial 59 Targanta Therapeutics Corporation 59 PHST 59 SinoBiomed 59 novel MetAP 2 59 Inc. NASDAQ CVTX 59 dedicated CHAT ROOM 59 CancerVax Corporation 59 Begins Clinical Trial 59 Hexvix ® 59 Gerdau S.A. 59 Adopts Stockholder Rights 59 FDA Clears 59 Sublicense 59 IND Filing 59 Private Placement Closed 59 Ucyclyd Pharma Inc. 59 BOCX 59 novel emulsion formulation 59 NPS Pharma 59 Frankfurt Freiverkehr 59 AKZO NOBEL 59 Inc. Nasdaq IMGN 59 GlaxoSmithKline Biologicals SA 59 Files Preliminary Proxy 59 Tezampanel 59 Ercole Biotech 59 platform HDL Mimetic 59 FOLOTYN ® 59 Expanded Indication 59 Warner Chilcott Limited 59 Inc. Nasdaq SUPG 59 NASDAQ PRCS 59 Senesco Technologies 59 EANS Adhoc 59 Medigene 59 DYAX 59 Friedreich Ataxia FRDA 59 Receives Commitment 59 Achieves Positive 59 TAG Tegernsee Immobilien u 59 Reiterates FY# Outlook 59 TiGenix 59 Selective Electrochemical Tumor Ablation 59 Astellas Deutschland GmbH 59 subsidiary AMDL Diagnostics 59 GEO Monitor IPO Newsflash 59 Hsp# Inhibitor 59 MultiCell Technologies 59 Non Dilutive 59 Adjourns Annual Meeting 59 Substantially Increases 59 Cerenis Therapeutics 59 Pharmion Corporation 59 S OMX LCP 59 Collaborators Publish 59 OTCBB QTXB 59 Telik Announces 59 PWRM.OB 59 Newmont Declares Regular 59 BioSante Pharmaceuticals Reports 59 Arana Therapeutics Limited 59 Inc. OTCBB VODG 59 molecular chaperone regulation 59 Announces Proposed Acquisition 59 LEVP 59 Completes Asset 59 non nucleoside inhibitor 59 Diatos 59 AMEX AOM 59 OTCBB ADXS 59 Material Fact 59 Announces License Agreement 59 RTTNews Biopharmaceutical 59 Further Cautionary Announcement 59 HealthSonix Inc. 59 Vaccine Adjuvant 59 Lifecycle Pharma 59 EntreMed Inc. 59 ESTAVIS AG 59 Biota Holdings Limited 59 Transcept Pharmaceuticals 59 Reaffirms Full 59 Puts Purchased 59 Vaxfectin R 59 INDICATED HIGHER 59 NASDAQ CYTO 59 NASDAQ REGN 59 Misonix Announces 59 Nasdaq ABRX 59 BioProgress plc 59 www.ucb.com 59 Kosan dependence 59 Lovaza TM 59 http:/www.presseportal.de 59 Q3 Profit Soars 59 www.ucb group.com 59 Aktiengesellschaft Release 59 Quark Pharmaceuticals 59 Closes Buyout 59 NASDAQ eMediaWorld.com mw http 59 APCVZ 59 Finalizes Acquisition 59 molecular therapeutics immunotherapies 59 Bearish Average Crossover 59 GVAX ®